185 related articles for article (PubMed ID: 35285743)
1. Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19.
Bartlett ML; Suwanmanee S; Peart Akindele N; Ghimire S; Chan AKP; Guo C; Gould SJ; Cox AL; Griffin DE
Viral Immunol; 2022 Apr; 35(3):259-272. PubMed ID: 35285743
[TBL] [Abstract][Full Text] [Related]
2. Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system.
Metcalf TU; Griffin DE
J Virol; 2011 Nov; 85(21):11490-501. PubMed ID: 21865385
[TBL] [Abstract][Full Text] [Related]
3. B-Cell Responses in Hospitalized Severe Acute Respiratory Syndrome Coronavirus 2-Infected Children With and Without Multisystem Inflammatory Syndrome.
Peart Akindele N; Pieterse L; Suwanmanee S; Griffin DE
J Infect Dis; 2022 Sep; 226(5):822-832. PubMed ID: 35436340
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.
Scheiblauer H; Nübling CM; Wolf T; Khodamoradi Y; Bellinghausen C; Sonntagbauer M; Esser-Nobis K; Filomena A; Mahler V; Maier TJ; Stephan C
J Clin Virol; 2022 Jan; 146():105052. PubMed ID: 34920374
[TBL] [Abstract][Full Text] [Related]
5. Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders.
Sauerwein KMT; Geier CB; Stemberger RF; Rossmanith R; Akyaman H; Illes P; Fischer MB; Eibl MM; Walter JE; Wolf HM
J Allergy Clin Immunol; 2023 Apr; 151(4):922-925. PubMed ID: 36463978
[TBL] [Abstract][Full Text] [Related]
6. Different long-term avidity maturation for IgG anti-spike and anti-nucleocapsid SARS-CoV-2 in hospitalized COVID-19 patients.
Heireman L; Boelens J; Coorevits L; Verhasselt B; Vandendriessche S; Padalko E
Acta Clin Belg; 2022 Jun; 77(3):653-657. PubMed ID: 34152944
[TBL] [Abstract][Full Text] [Related]
7. Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19.
Byazrova M; Yusubalieva G; Spiridonova A; Efimov G; Mazurov D; Baranov K; Baklaushev V; Filatov A
Clin Transl Immunology; 2021; 10(2):e1245. PubMed ID: 33552508
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection.
Tauzin A; Gendron-Lepage G; Nayrac M; Anand SP; Bourassa C; Medjahed H; Goyette G; Dubé M; Bazin R; Kaufmann DE; Finzi A
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336940
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan.
Hibino M; Watanabe S; Tobe S; Maeda K; Horiuchi S; Nishiguchi S; Iwase A; Uryu K; Kobayashi S; Kondo T
Respir Investig; 2022 Mar; 60(2):256-263. PubMed ID: 34924308
[TBL] [Abstract][Full Text] [Related]
10. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow GM
PLoS One; 2021; 16(1):e0244855. PubMed ID: 33507994
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year.
Disanto G; Galante A; Cantu' M; Sacco R; Mele F; Eisler JJ; Keller F; Bernasconi E; Sallusto F; Zecca C; Gobbi C
Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36396447
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.
Amellal H; Assaid N; Charoute H; Akarid K; Maaroufi A; Ezzikouri S; Sarih M
PLoS One; 2023; 18(7):e0288557. PubMed ID: 37437051
[TBL] [Abstract][Full Text] [Related]
14. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesch M; Andréll J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Sachs M; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarström L; Baldanti F; Marcotte H; Pan-Hammarström Q
Med; 2021 Mar; 2(3):281-295.e4. PubMed ID: 33589885
[TBL] [Abstract][Full Text] [Related]
15. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
[TBL] [Abstract][Full Text] [Related]
16. Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease.
Xu M; Jiang Y; Wang J; Liu J; Liu C; Liu D; Yang S
BMC Immunol; 2019 Jun; 20(1):16. PubMed ID: 31159728
[TBL] [Abstract][Full Text] [Related]
17. Incomplete IgG avidity maturation after seasonal coronavirus infections.
Struck F; Schreiner P; Staschik E; Wochinz-Richter K; Schulz S; Soutschek E; Motz M; Bauer G
J Med Virol; 2022 Jan; 94(1):186-196. PubMed ID: 34427932
[TBL] [Abstract][Full Text] [Related]
18. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.
Harrington WE; Trakhimets O; Andrade DV; Dambrauskas N; Raappana A; Jiang Y; Houck J; Selman W; Yang A; Vigdorovich V; Yeung W; Haglund M; Wallner J; Oldroyd A; Hardy S; Stewart SWA; Gervassi A; Van Voorhis W; Frenkel L; Sather DN
Cell Rep Med; 2021 Apr; 2(4):100253. PubMed ID: 33842901
[TBL] [Abstract][Full Text] [Related]
19. Antibody-secreting cells with a phenotype of Ki-67low, CD138high, CD31high, and CD38high secrete nonspecific IgM during primary hepatitis A virus infection.
Hong S; Lee HW; Chang DY; You S; Kim J; Park JY; Ahn SH; Yong D; Han KH; Yoo OJ; Shin EC
J Immunol; 2013 Jul; 191(1):127-34. PubMed ID: 23729443
[TBL] [Abstract][Full Text] [Related]
20. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
